Fluorescence Imaging Technology

Leveraging the integration of a sophisticated laser, high-speed imaging and a fluorescing agent with a strong record of safety, Novadaq enables surgeons to visualize natural blood flow, nerves, lymphatics and tumors in real-time. So whether it’s to assess blood flow indicative of graft functionality after a coronary artery bypass graft (CABG) procedure; tissue perfusion during plastic, micro and reconstructive surgery; blood flow and tissue perfusion in solid organ transplant, tumor or nerve identification during surgical urology procedures or choroidal vessel closure™ (CVC) after evaluation and treatment of wet Age-related Macular Degeneration (AMD), surgeons using Novadaq’s technology can be assured of procedural success before the patient leaves the operating room.

Image-Guided Revascularization Therapy -CO_² Laser Technology

CO₂ TMR technology is an effective angina relief therapy for diffusely diseased coronary vessels with poor targets for bypass. CO₂ technology (1000 watts) allows the Heart Laser to create a channel in a single pulse. The CO₂ Heart Laser 2's single pulse is synchronized with the heartbeat, firing only when the heart is at rest. This is the point at which the heart is at reduced risk of arrhythmia.

The CO₂ Heart Laser 2's channels have been reported to maintain tissue integrity and foster healing. These channels stimulate measurable perfusion, when using TMR to treat areas of the heart that other methods of treatment cannot. The straight and clean channels may lay a foundation for vascular growth and provide long-lasting pain relief.

Autofluorescence Endoscopic Technology

Novadaq has a comprehensive portfolio of autofluorescence endoscopic imaging technology with the vision to expand the applications for this technology to surgical guidance and, in particular, to improve delineation of tumour margins.  With an established clinical record in diagnostic imaging applications, this technology does not require the administration of a fluorescing agent, but instead utilizes naturally occurring fluorophors to assist physicians in discriminating between healthy and diseased tissue.  Novadaq is excited about the potential of this technology to provide surgeons with greater confidence of complete resection of diseased tissue and for improved tissue sparing and decreased morbidity.